Course Director:
Manju T. Beier, Pharm..D., FASCP
President, Geriatric Consultant Resources, LLC
Clinical Assistant Professor, College of Pharmacy
University of Michigan, Ann Arbor, Michigan, USA

Upon completion of this program the participants should be able to:

1. Describe the incidence and prevalence of epilepsy in the elderly.

2. List the classification of epilepsy, identify characteristics, and clinical manifestations of common seizure types encountered in the elderly.

3. Identify the etiology of seizures and exacerbating factors in the elderly.

4. Discuss the goals and principles of antiepileptic drug (AED) therapy in the elderly.

5. Outline the physiologic changes that accompany aging and their impact on the disposition of AEDs in the elderly.

6. List the Îold conventional AEDsâ and the Înewer second generationâ AEDs, and identify the appropriate AED for the specific seizure type.

7. Describe the limitations of the Îold conventional AEDsâ in the elderly.

8. Describe the clinical indications, pharmacokinetics, dosing guidelines, and adverse drug experiences of the newer AEDs.

9. List five reasons for obtaining therapeutic drug levels of AEDs in the elderly.

Target audience
Geriatric health-care practitioners

Accreditation
At this time we are offering CE for pharmacists only. The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

First Release Date: March 1998
Second Release date: July 2002
Expiration Date: July 2005

This program (Program {INDIVIDUAL PROGRAM NUMBER #203-999-02-602-H01)} qualifies for 0.15 CEUs (1.5 contact hours) of continuing pharmacy education. CEUs will be awarded provided that the participant reviews this site and scores 70% or better on the post test that follows. To receive a statement of credit, please complete the examination and evaluation that follows this program. A statement will be awarded and mailed to you within 4-6 weeks.

The information provided in these programs is intended solely for the continuing educational needs of health-care practitioners. The medications discussed in these programs have Food and Drug Administration approval in the US. Individuals should not exclusively rely upon the information provided in these programs.

The continuing education programs are offered ãas is.ä Geriatric Consultant Resources, LLC disclaims all warranties and representations, express or implied, with respect to the programs and the information contained therein, including without limitation any and all warranties of title, non infringement, merchantability, or fitness for any particular purpose. Without limiting the foregoing, Geriatric Consultant Resources LLC shall not be responsible for any inaccuracy or omission in the information contained in the programs, and shall have no liability whatsoever of any kind resulting from any claim or action arising out of the use of the programs.